Our investigators advance the study of infectious diseases and the pathogens that cause them through hands-on field work supporting basic science research as well as investigator-initiated and industry-sponsored clinical trials. more info
Conferences
Infectious Diseases Fellowship Program
Division-Sponsored Courses
Educational Videos
Doctor Visits
COVID-19: What you need to know from Montefiore
Schedule an appointment, refer a patient, Einstein-Montefiore ID treatment centers. more info
Policies, schedules, antibiotic booklet, and useful links. more info
Combating the COVID-19 Pandemic with Antibodies and a Patient DatabaseAlong with many other Einstein and Montefiore scientists and physicians, infectious disease expert Liise-anne Pirofski, M.D., is working overtime to confront COVID-19, the disease caused by the new coronavirus.
How blood from coronavirus survivors might save lives
Dr. Liise-anne Pirofski Speaks to CNN About New COVID-19 Clinical Trial
Publications
JCI article on SARS-Cov-2 viral and antibody kinetics argues that convalescent plasma (CP) therapy functions differently early and late in COVID-19.
JCI article Kinetics of Viral Load and Antibody Response in Relation to COVID-19 Severity.
Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework
Trial for Potential Coronavirus Treatment is Underway at Montefiore and Einstein Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection.
Hydroxychloroquine Clinical Trials Underway in New York to Treat Coronavirus Patients
Antibiotic treatment for COVID-19 complications could fuel resistant bacteria “We tend not to hold back on antibiotics in these patients,” Nori says, especially when that decision could mean life or death. “Is that a bad thing right now? I have trouble saying that it is.”
Covid-19 and Kidney Transplantation To the Editor: Kidney-transplant recipients appear to be at particularly high risk for critical Covid-19 illness due to chronic immunosuppression and coexisting conditions.
news & multimedia archive
Liise-anne Pirofski, M.D. (Bio)Professor, Department of Medicine (Infectious Diseases)Professor, Department of Microbiology & ImmunologyChief, Division of Infectious Diseases , Department of MedicineSelma and Dr. Jacques Mitrani Chair in Biomedical Research
June-2020
A 33 year old man presented with three days of fevers of 102 to 103oF and myalgias ... more info
Previous Cases
Global Health Center Website
NYC Department of Health
Centers for Disease Control
more ID resources
No Grand Rounds at this time